eighteen patients ( 6 breast cancer , 10 non-hodgkin 's lymphoma , 2 hodgkin 's disease ) were treated with high-dose cyclophosphamide ( 7 gr/mq ) , while 12 ( 2 breast cancer , 5 non-hodgkin 's lymphoma , 5 multiple myeloma ) were additionally treated with rhgm-csf for 14 days after cyclophosphamide .
C0010583
cyclophosphamide
C0026764
multiple myeloma